Yang H - Search Results

1

Myasthenia gravis patients with low plasma IL-6 and IFN-gamma benefit from etanercept treatment.

Tüzün E, Meriggioli MN, Rowin J, Yang H, Christadoss P. Tüzün E, et al. Among authors: yang h. J Autoimmun. 2005 May;24(3):261-8. doi: 10.1016/j.jaut.2005.01.013. J Autoimmun. 2005. PMID: 15848049 Clinical Trial.

2

Mapping myasthenia gravis-associated T cell epitopes on human acetylcholine receptors in HLA transgenic mice.

Yang H, Goluszko E, David C, Okita DK, Conti-Fine B, Chan TS, Poussin MA, Christadoss P. Yang H, et al. J Clin Invest. 2002 Apr;109(8):1111-20. doi: 10.1172/JCI14255. J Clin Invest. 2002. PMID: 11956249 Free PMC article.

3

Resistance to experimental autoimmune myasthenia gravis in IL-6-deficient mice is associated with reduced germinal center formation and C3 production.

Deng C, Goluszko E, Tüzün E, Yang H, Christadoss P. Deng C, et al. Among authors: yang h. J Immunol. 2002 Jul 15;169(2):1077-83. doi: 10.4049/jimmunol.169.2.1077. J Immunol. 2002. PMID: 12097416

4

B7-1 costimulatory molecule is critical for the development of experimental autoimmune myasthenia gravis.

Poussin MA, Tüzün E, Goluszko E, Scott BG, Yang H, Franco JU, Christadoss P. Poussin MA, et al. Among authors: yang h. J Immunol. 2003 Apr 15;170(8):4389-96. doi: 10.4049/jimmunol.170.8.4389. J Immunol. 2003. PMID: 12682276

5

Decreased expression of Src homology 2 domain-containing protein tyrosine phosphatase 1 reduces T cell activation threshold but not the severity of experimental autoimmune myasthenia gravis.

Deng C, Wu B, Yang H, Hussain RZ, Lovett-Racke AE, Christadoss P, Racke MK. Deng C, et al. Among authors: yang h. J Neuroimmunol. 2003 May;138(1-2):76-82. doi: 10.1016/s0165-5728(03)00119-x. J Neuroimmunol. 2003. PMID: 12742656

6

Induction of myasthenia gravis in HLA transgenic mice by immunization with human acetylcholine receptors.

Yang H, Goluszko E, David C, Okita DK, Conti-Fine B, Chan TS, Poussin MA, Christadoss P. Yang H, et al. Ann N Y Acad Sci. 2003 Sep;998:375-8. doi: 10.1196/annals.1254.044. Ann N Y Acad Sci. 2003. PMID: 14592899

7

Circulating immune complexes augment severity of antibody-mediated myasthenia gravis in hypogammaglobulinemic RIIIS/J mice.

Tüzün E, Scott BG, Yang H, Wu B, Goluszko E, Guigneaux M, Higgs S, Christadoss P. Tüzün E, et al. Among authors: yang h. J Immunol. 2004 May 1;172(9):5743-52. doi: 10.4049/jimmunol.172.9.5743. J Immunol. 2004. PMID: 15100321

8

ICOS is essential for the development of experimental autoimmune myasthenia gravis.

Scott BG, Yang H, Tüzün E, Dong C, Flavell RA, Christadoss P. Scott BG, et al. Among authors: yang h. J Neuroimmunol. 2004 Aug;153(1-2):16-25. doi: 10.1016/j.jneuroim.2004.04.019. J Neuroimmunol. 2004. PMID: 15265659

9

Cathepsin S is required for murine autoimmune myasthenia gravis pathogenesis.

Yang H, Kala M, Scott BG, Goluszko E, Chapman HA, Christadoss P. Yang H, et al. J Immunol. 2005 Feb 1;174(3):1729-37. doi: 10.4049/jimmunol.174.3.1729. J Immunol. 2005. PMID: 15661938

10

Human thyroglobulin peptide p2340 induces autoimmune thyroiditis in HLA-DR3 transgenic mice.

Karras E, Yang H, Lymberi P, Christadoss P. Karras E, et al. Among authors: yang h. J Autoimmun. 2005 Jun;24(4):291-6. doi: 10.1016/j.jaut.2005.02.002. Epub 2005 Apr 2. J Autoimmun. 2005. PMID: 15927791

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

61,412 results

Search Page

Filters